VQ OrthoCare Showcases Award-Winning Treatment Option for OA of the Knee at the AAOS Annual Meeting

BioniCare® Knee System Gives Hope to 27 Million; Estimated to Save Healthcare Industry $400 Million End Quote

Orange County, CA (1888PressRelease) February 04, 2012 - Responding to the need for an innovative, safe and affordable treatment option for osteoarthritis (OA) of the knee, VQ OrthoCare® will exhibit its award-winning BioniCare® Knee System at the American Academy of Orthopaedic Surgeons' (AAOS) Annual Meeting this February. Prescribed to more than 80,000 patients world-wide and cleared by the FDA in 2003, the groundbreaking BioniCare Knee System combines the joint unloading OActive™ or Eagle™ OA knee brace with BioniCare®, a non-invasive pulsed electrical stimulator that mimics the naturally occurring signal present in a healthy knee joint. Patients with OA who use the BioniCare Knee System have a greater ability to quickly relieve the pain and symptoms associated with OA of the knee, expedite their recovery time and defer more severe, high-risk treatment options such as total knee arthroplasty (TKA). Additionally, the implementation of the BioniCare Knee System by healthcare providers has the potential to save the healthcare industry an estimated $400 million annually in TKA deferrals.

In October 2011, a study featuring the BioniCare Knee System was published in Rheumatology News. The 20-month long study, conducted by VQ OrthoCare to analyze treatment options for OA of the knee, concluded that patients with OA who combined BioniCare with the OActive knee brace saw a substantial improvement of knee functionality in a shorter amount of time than patients who used either treatment option separately. The study confirmed that the combination proved to be 37 percent more effective than BioniCare alone and 39 percent more effective than the brace alone.

"The BioniCare Knee System provides the more than 27 million Americans affected by OA an alternative, non-invasive treatment option," said Jim Knape, president and founder, VQ OrthoCare. "Patients are not only able to defer surgery, but return to an active, pain-free life in less time. We invite all AAOS attendees to stop by our booth and learn more."

Founded in 1933, AAOS is the preeminent provider of musculoskeletal education to orthopaedic surgeons in the world. Its continuing medical education (CME) activities include the world-renowned Annual Meeting, multiple CME courses held around the country and its Orthopaedic Learning Center. Bringing together the best in orthopaedic education, research and technology, this year's 79th Annual Meeting will be held Feb. 8 - 10 at the Moscone Center in San Francisco. VQ OrthoCare will be exhibiting in Hall D at Booth 4471.

In addition to the BioniCare Knee System, VQ OrthoCare will also be presenting the BioniCare Hand System for rheumatoid arthritis, Catalyst Elite knee bracing and its new patient tracking technology BIO2000, the driving device behind the delivery of BioniCare. This new device provides VQ OrthoCare patients a Bluetooth tracking option that uploads their signal information to the BioniCare Patient Portal where they can track their treatment progress through charts and graphs, print reports for their physicians, and find arthritis-related information, stories and tips.

For more information on VQ OrthoCare, visit www.VQOrthoCare.com or call (800) 266-6969. For additional information on AAOS Annual Meeting, visit www.aaos.org.

About VQ OrthoCare®:
Founded in 1989 and based in Irvine, Calif., VQ OrthoCare® is a leading manufacturer and provider of non-invasive medical solutions focused on bone, joint and soft-tissue conditions. VQ OrthoCare's commitment to treating patients with respect and supporting them in achieving optimum outcomes is unmatched in the industry. Services include in-home patient fitting of braces and other medical devices, and technology-enabled compliance monitoring. VQ OrthoCare's products include: SurgiStim4, OrthoStim4, Eagle, Catalyst and OActive knee bracing, Fast Start EMS, Fast Start HVPC, VQ Vector, and the BioniCare system. VQ OrthoCare is registered with the U.S. Food and Drug Administration as a medical device manufacturer and specification developer.

###

space

Other Related Press Releases